Since accumulated evidences supporting a key role for MDM4 in the regulation of P53 tumor suppression function [14]–[17], it is biologically plausible to speculate that the decreased ESCC risk observed among MDM4 rs4245739 C allele carriers result from the increased tumor suppressor activity of P53. This evidence concerns the gene MDM4 and esophageal squamous cell carcinoma.